| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 81,799 | 49,974 | 50,888 | 195,499 | | Cost of Revenue | 30,696 | 29,096 | 12,528 | 165,234 | | | Gross Profit | 51,103 | 20,878 | 38,360 | 30,265 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,940 | (3,605) | 15,716 | (17,913) | | Non Recurring |
-
|
-
|
-
| 9,354 | | Others | 12,269 | 8,752 | 8,621 | 12,856 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 29,894 | 15,731 | 14,023 | 25,968 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,458) | 4,234 | 4,230 | 4,245 | | Earnings Before Interest And Taxes | 27,436 | 19,965 | 18,253 | 30,213 | | Interest Expense | (3,571) | 1,786 | 1,785 | (1,231) | | Income Before Tax | 31,007 | 18,179 | 16,468 | 31,444 | | Income Tax Expense | 283 | 55 | (490) | 5,691 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 29,607 | 18,124 | 16,958 | 25,753 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 22,983 | 18,124 | 16,958 | 25,753 | | Preferred Stock And Other Adjustments | 702 | (702) |
-
|
-
| | | Net Income Applicable To Common Shares | $23,685 | $17,422 | $16,958 | $25,753 |
|
0.51% Nasdaq 
Income Statement
